Home

длъжник месинг Не мога да чета или пиша kapos ioannis cardiology бръснач Advance предотвратявам

Multiple pathologies in one standard cardiac MR examination: whole in one |  SpringerLink
Multiple pathologies in one standard cardiac MR examination: whole in one | SpringerLink

Recordings CMR JOURNAL CLUB
Recordings CMR JOURNAL CLUB

Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural  Success, and Recurrence of Disease - ScienceDirect
Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease - ScienceDirect

Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural  Success, and Recurrence of Disease - ScienceDirect
Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease - ScienceDirect

Recordings CMR JOURNAL CLUB
Recordings CMR JOURNAL CLUB

Ioannis Kapos – Medical Doctor – Heart Clinic Zurich (Switzerland) |  LinkedIn
Ioannis Kapos – Medical Doctor – Heart Clinic Zurich (Switzerland) | LinkedIn

Ioannis P. Capos - Training Manager Vian S.A. - Vianex SA | LinkedIn
Ioannis P. Capos - Training Manager Vian S.A. - Vianex SA | LinkedIn

Dr. med. Ioannis Kapos | Cardiology Heart Clinic Hirslanden
Dr. med. Ioannis Kapos | Cardiology Heart Clinic Hirslanden

Heart teams of the heart clinic
Heart teams of the heart clinic

Dr. med. Ioannis Kapos | Hirslanden Group
Dr. med. Ioannis Kapos | Hirslanden Group

Recordings CMR JOURNAL CLUB
Recordings CMR JOURNAL CLUB

Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural  Success, and Recurrence of Disease | JACC: Cardiovascular Imaging
Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease | JACC: Cardiovascular Imaging

Ioannis Kapos MD | Cardiac Imaging and Cardiology Zurich
Ioannis Kapos MD | Cardiac Imaging and Cardiology Zurich

Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A  phase II, randomized, double-blind, multi-center, placebo-controlled trial  - ScienceDirect
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial - ScienceDirect

Heart Clinic Zurich (Switzerland) | LinkedIn
Heart Clinic Zurich (Switzerland) | LinkedIn

Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural  Success, and Recurrence of Disease - ScienceDirect
Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease - ScienceDirect

Dr. med. Ioannis Kapos | Cardiology Heart Clinic Hirslanden
Dr. med. Ioannis Kapos | Cardiology Heart Clinic Hirslanden

Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A  phase II, randomized, double-blind, multi-center, placebo-controlled trial  - ScienceDirect
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial - ScienceDirect

Mareike GASTL | Heinrich-Heine-Universität Düsseldorf, Düsseldorf | HHU
Mareike GASTL | Heinrich-Heine-Universität Düsseldorf, Düsseldorf | HHU

Dr. med. Ioannis Kapos | Cardiology Heart Clinic Hirslanden
Dr. med. Ioannis Kapos | Cardiology Heart Clinic Hirslanden

Cardiovascular Medicine - Value of echocardiography in differentiation of  acute dyspnoea
Cardiovascular Medicine - Value of echocardiography in differentiation of acute dyspnoea

Cardiovascular Medicine - Value of echocardiography in differentiation of  acute dyspnoea
Cardiovascular Medicine - Value of echocardiography in differentiation of acute dyspnoea

Recordings CMR JOURNAL CLUB
Recordings CMR JOURNAL CLUB

Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural  Success, and Recurrence of Disease | JACC: Cardiovascular Imaging
Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease | JACC: Cardiovascular Imaging

Profile | Ioannis Kapos | NEJM Resident 360
Profile | Ioannis Kapos | NEJM Resident 360